Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
18384253 |
Age 24.5 ± 3, Gender ⚥ |
0.72 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 40.8 ± 5.6, Gender ⚥ |
1.03 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 55.6 ± 3.7, Gender ⚥ |
1.42 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
17474139 |
Age 36.6 ± 5.5, Gender ⚥ |
33.8 (mmol/mol ) |
H-NMR |
urine |
17474139 |
Age 54.5 ± 7.6, Gender ⚥ |
34.1 (mmol/mol ) |
H-NMR |
urine |
23701591 |
Age [34-39], Gender ⚥ (American population) |
2.0 (signal intensity) |
HNMR |
urine |
23701591 |
Age [72-84], Gender ⚥ (American population) |
1.68 (signal intensity) |
HNMR |
urine |
27374292 |
Age [25–35] (median=32), Gender ♀ (Japanese) |
0.927251 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–65] (median=60), Gender ♀ (Japanese) |
1.00017 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
0.965668 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.133156 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
29090929 |
Age 42 ± 12, Gender ♀ |
-0.24 (log2 ratio) |
NMR |
blood |
29090929 |
Age 41 ± 12, Gender ♂ |
-0.127 (log2 ratio) |
NMR |
blood |